Skin Cancer Study May Pave Way for More Individualized Treatments – 3
Narrator: This is NIH Health Matters. Findings reported in the journal Nature Genetics implicate a group of enzymes in skin cancer. Dr. Yardena Samuels at the National Human Genome Research Institute says researchers have spent decades studying enzymes called MMPs.
Samuels: Members of this family were thought to be oncogenes meaning they activate growth… We are now showing that some of these are actually suppressing growth… So this study may help explain the disappointing performance of some of these drugs used in clinical trials in the past.
Narrator: Enzymes can play a functional role in tumor growth and spread of the disease. For more this, and more about medical research, visit www.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.